Cargando…
Liposome-Based Drug Delivery Systems in Cancer Immunotherapy
Cancer immunotherapy has shown remarkable progress in recent years. Nanocarriers, such as liposomes, have favorable advantages with the potential to further improve cancer immunotherapy and even stronger immune responses by improving cell type-specific delivery and enhancing drug efficacy. Liposomes...
Autores principales: | Gu, Zili, Da Silva, Candido G., Van der Maaden, Koen, Ossendorp, Ferry, Cruz, Luis J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694212/ https://www.ncbi.nlm.nih.gov/pubmed/33158166 http://dx.doi.org/10.3390/pharmaceutics12111054 |
Ejemplares similares
-
Cationic Liposomes: A Flexible Vaccine Delivery System for Physicochemically Diverse Antigenic Peptides
por: Heuts, Jeroen, et al.
Publicado: (2018) -
Cationic Nanoparticle-Based Cancer Vaccines
por: Heuts, Jeroen, et al.
Publicado: (2021) -
Lipid‐based nanoparticles as drug delivery systems for cancer immunotherapy
por: Hao, Yang, et al.
Publicado: (2023) -
Microneedle-based drug and vaccine delivery via nanoporous microneedle arrays
por: van der Maaden, Koen, et al.
Publicado: (2015) -
Bacterial Cellulose as Drug Delivery System for Optimizing Release of Immune Checkpoint Blocking Antibodies
por: Chung, Chih Kit, et al.
Publicado: (2022)